Verification register Bio, Health & Neuro
Current reading
Readiness band and full integer triple
AI-assisted assembly · derived results
Readiness band
Ready
Primary summary from verified readiness
- Confidence
- 63% · fresh
- Computed at
- 2026-08-20T10:56:05.345626+00:00
- Claimed
- 80
- Reported
- 77
- Verified
- 69
- Gap
- +11
Public ambition and stated capability
Observed practitioner reporting
Independently supported evidence
Claimed leads verified
Evidence strength Critical
Decision
What the current evidence supports
Human editorial judgment · 2026-08-20
Track; not yet
- Why
- Approval is accelerated and conditional on a still-pending confirmatory trial, and the pivotal-trial toxicity profile (84.3% Grade 3/4 neutropenia, 4.9% fatal AEs, boxed warnings + REMS) is material enough that the therapy's real-world risk/benefit maturity is not yet settled even though initial efficacy data (41% vs 21% MRD-negative CR, p<.0001) is strong.
- Next
- Re-check at the EXCALIBER-RRMM confirmatory PFS/OS readout and at post-launch REMS/pharmacovigilance updates before upgrading the readiness classification toward full approval status.
Constraints
Blockers
No named blocker is present in the current public projection.
Evidence summary
Derived counts
AI-assisted assembly
- Total
- 5
- Tier 1
- 0
- Tier 2
- 2
- Tier 3
- 3
- Supports
- 3
- Contradicts
- 1
- Context
- 1
- Latest observed
- 2026-08-14
Counts and dates only. Raw signals, private excerpts, trust records, and internal corpus material are not published here.
Publication record
Revisions
Initial public reading
- 2026-08-17 Reading moved from ready to ready.